Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Oak Street Health

Oak Street Health: Q1 Earnings Insights

Oak Street Health (NYSE:OSH) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Oak Street Health missed estimated earnings by 10.26%, reporting an EPS of $-0.43 versus an estimate of $-0.39.

Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022

What 7 Analyst Ratings Have To Say About Oak Street Health

What 7 Analyst Ratings Have To Say About Oak Street Health

Over the past 3 months, 7 analysts have published their opinion on Oak Street Health (NYSE:OSH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022

Executives Sell About $30M Of 3 Stocks

Although crude oil futures traded lower on Friday, there were a few notable insider trades.

Expert Ratings For Oak Street Health

Over the past 3 months, 7 analysts have published their opinion on Oak Street Health (NYSE:OSH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

What 6 Analyst Ratings Have To Say About Oak Street Health

Analysts have provided the following ratings for Oak Street Health (NYSE:OSH) within the last quarter:

inkl

Read news from The Economist, FT, and more,
with one subscription

Oak Street Health's Return On Capital Employed Insights

Oak Street Health's Return On Capital Employed Insights

Benzinga Pro data, Oak Street Health (NYSE:OSH) reported Q4 sales of $394.10 million. Earnings fell to a loss of $140.30 million, resulting in a 27.66% decrease from last quarter.

Where Oak Street Health Stands With Analysts

Where Oak Street Health Stands With Analysts

Over the past 3 months, 4 analysts have published their opinion on Oak Street Health (NYSE:OSH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

1 2

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play